Cargando…
Biological Markers and Alzheimer Disease: A Canadian Perspective
Decreased β-amyloid(1-42) and increased phospho-tau protein levels in the cerebrospinal fluid (CSF) are currently the most accurate chemical neurodiagnostics of sporadic Alzheimer disease (AD). A report (2007) of the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (200...
Autor principal: | Schipper, Hyman M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929634/ https://www.ncbi.nlm.nih.gov/pubmed/20811568 http://dx.doi.org/10.4061/2010/978182 |
Ejemplares similares
-
MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders
por: Maes, Olivier C, et al.
Publicado: (2009) -
Development and validation of a salivary tau biomarker in Alzheimer's disease
por: Pekeles, Heather, et al.
Publicado: (2018) -
The Usefulness of Biological and Neuroimaging Markers for the Diagnosis of Early-Onset Alzheimer's Disease
por: Padovani, Alessandro, et al.
Publicado: (2011) -
Medical cannabis – the Canadian perspective
por: Ko, Gordon D, et al.
Publicado: (2016) -
MicroRNA Expression in Alzheimer Blood Mononuclear Cells
por: Schipper, Hyman M., et al.
Publicado: (2007)